Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8829)
All Articles published online
|
Publishing Process of This Article
|
May 14, 2017 (publication date) through Jul 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang X, Oishi N, Shimakami T, Yamashita T, Honda M, Murakami S, Kaneko S. Hepatitis B virus X protein induces hepatic stem cell-like features in hepatocellular carcinoma by activating KDM5B. World J Gastroenterol 2017; 23(18): 3252-3261 [PMID: 28566884 DOI: 10.3748/wjg.v23.i18.3252] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i18/3252.htm |
| Number | Citing Articles |
| 1 |
Yuting Meng, Zheyue Shu, Xueyao Wang, Liang Hong, Baohua Wang, Jingjing Jiang, Kangxin He, Qingyi Cao, Fan Shi, Hai Wang, Lan Gong, Hongyan Diao. Hepatitis B Virus–Mediated m6A Demethylation Increases Hepatocellular Carcinoma Stemness and Immune Escape. Molecular Cancer Research 2024; 22(7): 642 doi: 10.1158/1541-7786.MCR-23-0720
|
| 2 |
Junhui Xue, Zhengyi Cao, Yuning Cheng, Jiyin Wang, Yujuan Liu, Ruixiang Yang, Hui Li, Wei Jiang, Gang Li, Wenhui Zhao, Xiaowei Zhang. Acetylation of alpha-fetoprotein promotes hepatocellular carcinoma progression. Cancer Letters 2020; 471: 12 doi: 10.1016/j.canlet.2019.11.043
|
| 3 |
Bruna G G Pinto, Antonio E R Oliveira, Youvika Singh, Leandro Jimenez, Andre N A Gonçalves, Rodrigo L T Ogava, Rachel Creighton, Jean Pierre Schatzmann Peron, Helder I Nakaya. ACE2 Expression Is Increased in the Lungs of Patients With Comorbidities Associated With Severe COVID-19. The Journal of Infectious Diseases 2020; 222(4): 556 doi: 10.1093/infdis/jiaa332
|
| 4 |
Marisol Salgado-Albarrán, Erick I. Navarro-Delgado, Aylin Del Moral-Morales, Nicolas Alcaraz, Jan Baumbach, Rodrigo González-Barrios, Ernesto Soto-Reyes. Comparative transcriptome analysis reveals key epigenetic targets in SARS-CoV-2 infection. npj Systems Biology and Applications 2021; 7(1) doi: 10.1038/s41540-021-00181-x
|
| 5 |
Mengjiao Xu, Liu Yang, Yanjie Lin, Yao Lu, Xiaoyue Bi, Tingting Jiang, Wen Deng, Lu Zhang, Wei Yi, Yao Xie, Minghui Li. Emerging nanobiotechnology for precise theranostics of hepatocellular carcinoma. Journal of Nanobiotechnology 2022; 20(1) doi: 10.1186/s12951-022-01615-2
|
| 6 |
Yang Zheng, Lili Tang, Guojiang Chen, Ziling Liu. Comprehensive Bioinformatics Analysis of Key Methyltransferases and Demethylases for Histone Lysines in Hepatocellular Carcinoma. Technology in Cancer Research & Treatment 2020; 19: 153303382098328 doi: 10.1177/1533033820983284
|
| 7 |
Yun-Dong Fu, Ming-Jie Huang, Jia-Wen Guo, Ya-Zhen You, Hong-Min Liu, Li-Hua Huang, Bin Yu. Targeting histone demethylase KDM5B for cancer treatment. European Journal of Medicinal Chemistry 2020; 208: 112760 doi: 10.1016/j.ejmech.2020.112760
|
| 8 |
Yoshinobu Shigekawa, Shinya Hayami, Masaki Ueno, Atsushi Miyamoto, Norihiko Suzaki, Manabu Kawai, Seiko Hirono, Ken-ichi Okada, Ryuji Hamamoto, Hiroki Yamaue. Overexpression of KDM5B/JARID1B is associated with poor prognosis in hepatocellular carcinoma. Oncotarget 2018; 9(76): 34320 doi: 10.18632/oncotarget.26144
|
| 9 |
Wenting Li, Xiaoqiong Duan, Chuanlong Zhu, Xiao Liu, Andre J. Jeyarajan, Min Xu, Zeng Tu, Qiuju Sheng, Dong Chen, Chuanwu Zhu, Tuo Shao, Zhimeng Cheng, Shadi Salloum, Esperance A. Schaefer, Annie J. Kruger, Jacinta A. Holmes, Raymond T. Chung, Wenyu Lin. Hepatitis B and Hepatitis C Virus Infection Promote Liver Fibrogenesis through a TGF-β1–Induced OCT4/Nanog Pathway. The Journal of Immunology 2022; 208(3): 672 doi: 10.4049/jimmunol.2001453
|
| 10 |
Ali A. Rabaan, Mohammed Aljeldah, Basim R. Al Shammari, Roua A. Alsubki, Jawaher Alotaibi, Yousef N. Alhashem, Neda A. Alali, Tarek Sulaiman, Zainab Alsalem, Huda A. Bajunaid, Mohammed Garout, Heba A. Alsaffar, Souad A. Almuthree, Doha Hudhaiah, Azhar M. Alzaher, Fatimah A. Alshaikh, Amer Alshengeti, Mustafa A. Najim, Ramadan Abdelmoez Farahat, Ranjan K. Mohapatra. Epigenetic Targets and Pathways Linked to SARS-CoV-2 Infection and Pathology. Microorganisms 2023; 11(2): 341 doi: 10.3390/microorganisms11020341
|
| 11 |
Bing Zhao, Qianqian Liang, Hongmei Ren, Xinhui Zhang, Yang Wu, Kun Zhang, Li-Ying Ma, Yi-Chao Zheng, Hong-Min Liu. Discovery of pyrazole derivatives as cellular active inhibitors of histone lysine specific demethylase 5B (KDM5B/JARID1B). European Journal of Medicinal Chemistry 2020; 192: 112161 doi: 10.1016/j.ejmech.2020.112161
|
| 12 |
Nobuaki Funahashi, Hikari Okada, Ryo Kaneko, Kouki Nio, Taro Yamashita, Naohiko Koshikawa. Hepatocyte transformation is induced by laminin γ2 monomer. Cancer Science 2024; doi: 10.1111/cas.16265
|
| 13 |
Ruiqi Liu, Jiajun Wu, Haiwei Guo, Weiping Yao, Shuang Li, Yanwei Lu, Yongshi Jia, Xiaodong Liang, Jianming Tang, Haibo Zhang. Post‐translational modifications of histones: Mechanisms, biological functions, and therapeutic targets. MedComm 2023; 4(3) doi: 10.1002/mco2.292
|
| 14 |
Yi-Chao Zheng, Jiao Chang, Lin-Chen Wang, Hong-Mei Ren, Jing-Ru Pang, Hong-Min Liu. Lysine demethylase 5B (KDM5B): A potential anti-cancer drug target. European Journal of Medicinal Chemistry 2019; 161: 131 doi: 10.1016/j.ejmech.2018.10.040
|